PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese CRSwNP Patients
Status: Recruiting
Location: See all (16) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Participant must be 16 years of age or older, at the time of signing the informed consent.
• Participants with a documented diagnosis of CRSwNP.
• Endoscopic nasal polypectomy is performed during the screening period.
• Voluntarily participate and sign the informed consent form as described in A 3.
• No history or current psychiatric disorders, with normal cognitive functions including understanding, expression, and orientation.
Locations
Other Locations
China
Research Site
RECRUITING
Changchun
Research Site
RECRUITING
Chengdu
Research Site
RECRUITING
Guangzhou
Research Site
RECRUITING
Guangzhou
Research Site
RECRUITING
Guangzhou
Research Site
NOT_YET_RECRUITING
Haikou
Research Site
RECRUITING
Nanchang
Research Site
RECRUITING
Nanjing
Research Site
RECRUITING
Nanning
Research Site
WITHDRAWN
Qingdao
Research Site
RECRUITING
Shanghai
Research Site
RECRUITING
Shenzhen
Research Site
RECRUITING
Ürümqi
Research Site
RECRUITING
Wuhan
Research Site
RECRUITING
Wuhan
Research Site
RECRUITING
Xiamen
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2026-03-20
Estimated Completion Date: 2027-10-21
Participants
Target number of participants: 200
Treatments
Standard of Care Endoscopic Sinus Surgery (ESS)
Although this study is non-interventional and observational in nature regarding treatment decisions, it is registered as an interventional study focusing on the Standard-of-Care (SoC) Functional Endoscopic Sinus Surgery (FESS) as the index procedure.~The intervention serves as the baseline event for the prospective evaluation of real-world outcomes. The study aims to assess the clinical trajectory (including SNOT-22, Nasal Polyp Score, and CT findings) following this standard clinical procedure over a 52-week period.~The surgery is performed strictly according to clinical routine, local guidelines, and the investigator's professional discretion.
Related Therapeutic Areas
Sponsors
Leads: AstraZeneca